411 related articles for article (PubMed ID: 29104130)
21. Twice-daily proton pump inhibitor therapy does not decrease the frequency of reflux episodes during nocturnal recumbency in patients with refractory GERD: analysis of 200 patients using multichannel intraluminal impedance-pH testing.
Clayton SB; Rife CC; Singh ER; Kalbfleisch JH; Castell DO
Dis Esophagus; 2012; 25(8):682-6. PubMed ID: 22292567
[TBL] [Abstract][Full Text] [Related]
22. Management of supragastric belching.
Velosa M; Sergeev I; Sifrim D
Neurogastroenterol Motil; 2022 Feb; 34(2):e14316. PubMed ID: 34984763
[TBL] [Abstract][Full Text] [Related]
23. Speech Therapy as Treatment for Supragastric Belching.
Ten Cate L; Herregods TVK; Dejonckere PH; Hemmink GJM; Smout AJPM; Bredenoord AJ
Dysphagia; 2018 Oct; 33(5):707-715. PubMed ID: 29574541
[TBL] [Abstract][Full Text] [Related]
24. Gastroesophageal Reflux Characteristics in Supragastric Belching Patients With Positive Versus Negative pH Monitoring: An Evidence of Secondary Gastroesophageal Reflux Disease From Excessive Belching.
Keeratichananont S; Patcharatrakul T; Gonlachanvit S
J Neurogastroenterol Motil; 2023 Jul; 29(3):343-351. PubMed ID: 37417261
[TBL] [Abstract][Full Text] [Related]
25. Gastroesophageal reflux disease-related symptom recurrence in patients discontinuing proton pump inhibitors for Bravo
Schey R; Alla SP; Midani D; Parkman HP
Rev Gastroenterol Mex; 2017; 82(4):277-286. PubMed ID: 28385467
[TBL] [Abstract][Full Text] [Related]
26. Prevalence and clinical characteristics of refractoriness to optimal proton pump inhibitor therapy in non-erosive reflux disease.
Ribolsi M; Cicala M; Zentilin P; Neri M; Mauro A; Efthymakis K; Petitti T; Savarino V; Penagini R
Aliment Pharmacol Ther; 2018 Nov; 48(10):1074-1081. PubMed ID: 30294924
[TBL] [Abstract][Full Text] [Related]
27. Role of esophageal manometry and 24-h pH testing in patients with refractory reflux symptoms.
Jain M; Agrawal V
Indian J Gastroenterol; 2020 Apr; 39(2):165-170. PubMed ID: 32388711
[TBL] [Abstract][Full Text] [Related]
28. Identification of Different Phenotypes of Esophageal Reflux Hypersensitivity and Implications for Treatment.
Sawada A; Guzman M; Nikaki K; Sonmez S; Yazaki E; Aziz Q; Woodland P; Rogers B; Gyawali CP; Sifrim D
Clin Gastroenterol Hepatol; 2021 Apr; 19(4):690-698.e2. PubMed ID: 32272249
[TBL] [Abstract][Full Text] [Related]
29. Supragastric belching: Pathogenesis, diagnostic issues and treatment.
Popa SL; Surdea-Blaga T; David L; Stanculete MF; Picos A; Dumitrascu DL; Chiarioni G; Ismaiel A; Dumitrascu DI
Saudi J Gastroenterol; 2022; 28(3):168-174. PubMed ID: 35562166
[TBL] [Abstract][Full Text] [Related]
30. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S
Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
[TBL] [Abstract][Full Text] [Related]
31. Supragastric Belching: Prevalence and Association With Gastroesophageal Reflux Disease and Esophageal Hypomotility.
Koukias N; Woodland P; Yazaki E; Sifrim D
J Neurogastroenterol Motil; 2015 Jul; 21(3):398-403. PubMed ID: 26130635
[TBL] [Abstract][Full Text] [Related]
32. Effects of Diaphragmatic Breathing on the Pathophysiology and Treatment of Upright Gastroesophageal Reflux: A Randomized Controlled Trial.
Halland M; Bharucha AE; Crowell MD; Ravi K; Katzka DA
Am J Gastroenterol; 2021 Jan; 116(1):86-94. PubMed ID: 33009052
[TBL] [Abstract][Full Text] [Related]
33. Globus sensation caused by gastroesophageal reflux disease.
Tokashiki R; Yamaguchi H; Nakamura K; Suzuki M
Auris Nasus Larynx; 2002 Oct; 29(4):347-51. PubMed ID: 12393039
[TBL] [Abstract][Full Text] [Related]
34. Characteristics of refractory gastroesophageal reflux disease (GERD) symptoms -is switching proton pump inhibitors based on the patient's CYP2C19 genotype an effective management strategy?
Takeuchi T; Oota K; Harada S; Edogawa S; Kojima Y; Sanomura M; Sakaguchi M; Hayashi K; Hongoh Y; Itabashi T; Kitae H; Hoshimoto M; Takeuchi N; Higuchi K
Intern Med; 2015; 54(2):97-105. PubMed ID: 25742999
[TBL] [Abstract][Full Text] [Related]
35. Behavioral therapy is superior to follow-up without intervention in patients with supragastric belching-A randomized study.
Punkkinen J; Nyyssönen M; Walamies M; Roine R; Sintonen H; Koskenpato J; Haakana R; Arkkila P
Neurogastroenterol Motil; 2022 Feb; 34(2):e14171. PubMed ID: 33991432
[TBL] [Abstract][Full Text] [Related]
36. Sleep disturbances and refractory gastroesophageal reflux disease symptoms in patients receiving once-daily proton pump inhibitors and efficacy of twice-daily rabeprazole treatment.
Fujiwara Y; Habu Y; Ashida K; Kusano M; Higuchi K; Arakawa T
Digestion; 2013; 88(3):145-52. PubMed ID: 24008338
[TBL] [Abstract][Full Text] [Related]
37. Randomized controlled trial of transoral incisionless fundoplication vs. proton pump inhibitors for treatment of gastroesophageal reflux disease.
Witteman BP; Conchillo JM; Rinsma NF; Betzel B; Peeters A; Koek GH; Stassen LP; Bouvy ND
Am J Gastroenterol; 2015 Apr; 110(4):531-42. PubMed ID: 25823768
[TBL] [Abstract][Full Text] [Related]
38. Long-term Outcomes of Patients Receiving a Magnetic Sphincter Augmentation Device for Gastroesophageal Reflux.
Ganz RA; Edmundowicz SA; Taiganides PA; Lipham JC; Smith CD; DeVault KR; Horgan S; Jacobsen G; Luketich JD; Smith CC; Schlack-Haerer SC; Kothari SN; Dunst CM; Watson TJ; Peters J; Oelschlager BK; Perry KA; Melvin S; Bemelman WA; Smout AJ; Dunn D
Clin Gastroenterol Hepatol; 2016 May; 14(5):671-7. PubMed ID: 26044316
[TBL] [Abstract][Full Text] [Related]
39. New treatment method for refractory gastroesophageal reflux disease (GERD): C-BLART (clip band ligation anti-reflux therapy)-a short-term study.
Liu S; Chai N; Zhai Y; Zou J; Feng X; Li Z; Li L; Zhang X; Wang X; Wang S; Linghu EQ
Surg Endosc; 2020 Oct; 34(10):4516-4524. PubMed ID: 31728750
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of hangeshashinto for treatment of GERD refractory to proton pump inhibitors : Usual dose proton pump inhibitors plus hangeshashinto versus double-dose proton pump inhibitors: randomized, multicenter open label exploratory study.
Takeuchi T; Hongo H; Kimura T; Kojima Y; Harada S; Ota K; Takeuchi N; Noguchi T; Inoue T; Murano M; Higuchi K
J Gastroenterol; 2019 Nov; 54(11):972-983. PubMed ID: 31037449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
